anti-IL-3R antibody (Tongji Medical College)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameanti-IL-3R antibody (Tongji Medical College)
Drug Alias Name5A2
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInterleukin 3 receptor antagonists
TargetsInterleukin 3 receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesTongji Medical College
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTongji Medical College
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A